Clolar OverviewClofarabine is a purine nucleoside antimetabolite marketed in the US and Canada as Clolar. In Europe and Australia/New Zealand the product is marketed under the name Evoltra. It is FDA-approved for treating relapsed or refractory acute lymphoblastic leukaemia (ALL) in children after at least two other types of treatment have failed. Some investigations of effectiveness in cases of acute myeloid leukaemia (AML) and juvenile myelomonocytic leukaemia (JMML) have been carried out. Ongoing trials...
Read more Clolar Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Clofarabine
Recent Clolar Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 1mg/ml, 20mg/20ml, 20mg/20ml (1mg/ml)
- Solution: 20mg/20ml (1mg/ml)
NDC Database Records for Clolar: (3 results)Sorted by National Drug Code
- 0024-5860 Clolar 1 mg/ml Intravenous Injection by Sanofi-aventis U.S. LLC
- 0024-5917 Clolar 1 mg/ml Intravenous Injection by Sanofi-aventis U.S. LLC
- 58468-0100 Clolar 1 mg/ml Intravenous Injection by Genzyme Corporation